Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 45

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 % antibiotics CAP ABRS AOM isolates aeruginosa activity microbiota incidence pharyngitis aureus typhimurium pneumonia A.
2 pneumoniae infections community-acquired therapy otitis NDM-1 pseudomonas strains commensal consumption acute pharyngitis S. cells patients baumannii
3 bacterial antibiotic legionella amoxicillin media gene pseudomonas aeruginosa coli NP patient-days case s. aureus albicans HAP a. baumannii
4 respiratory antimicrobial pneumonia sinus ear M. gram-negative E. colonization UAT periodontal food protein cultures MDR
5 viruses resistance atypical antibiotic middle TB K. e. coli microbiome taiwan GAS humans χ3987 blood CRS
6 influenzae recent community-acquired pneumonia high-dose OME dispar spp bactericidal microbe carbapenems gulae hajj in vitro NHAP CI
7 s. pneumoniae management pneumoniae duration acute otitis media assay organisms MIC URT 2003 sore cons candida bali gowns
8 detected agents m. pneumoniae antibiotic therapy otitis media diffusion surfaces concentration abundance decreased report pilgrims surface single aor
9 viral effective mycoplasma pneumoniae days acute m. dispar coli inhibitory 16S % GABHS shigella vitro pleural de
10 PCR include chlamydia day middle ear resistance acinetobacter salmonella healthy PCV13 acute mupirocin virulence mros hands
11 children common mycoplasma treatment OM clonal nosocomial minimum corynebacterium hospital throat flexneri avium anaerobic gloves
12 pathogens therapy sputum amoxicillin/clavulanate tube somnus methicillin-resistant salmonella spp Y. ASP streptococcal rtis subsp aetiology 95
13 catarrhalis important severe failure otopathogens mtp p. aeruginosa antimicrobial activity commensal bacteria 2010 dogs methicillin-resistant s. aureus sal-06mab HCAP en
14 streptococcus clinical pneumophila weeks children respocheck handles inhibition communities annual typically carriage cmpa aspirate HCW
15 bacteria article diagnosis β-lactams effusion h. somnus enterococcus isolated pestis significantly periodontal disease schweitzeri pyats-1 NPA h. influenza
16 virus studies empirical antibiotic treatment recurrent disc diffusion klebsiella colistin profiles MRSA peritonsillar abscess wound infections adhesins aps hcws
17 culture major typical initial nasopharyngeal disc escherichia coli GR-SU diversity vs. necrophorum beijing growth pleural fluid minutes
18 found diseases early 4 eustachian triplex multi-resistant tested genera era formulation staphylococcus cell etiology ARS
19 H. current cases recommended eustachian tube integrons exhaled GRA controls trends p. gulae colonizing tissue community‐acquired AMC/DCBA
20 influenza drugs chlamydia pneumoniae high-dose amoxicillin microbial bovis laryngoscope IASOS mucosal extended-spectrum peritonsillar helvum mice community‐acquired pneumonia fungi
21 haemophilus review mixed mg pathogenesis camels protocol mg/l nasopharyngeal microbiota s. marcescens hoylei MAP27 paratuberculosis radiologically lozenges
22 = bacterial pneumonia patients efficacy hearing sonnei ventilator-associated phylogroup gut mm−3 authors requirement receptors april tratamiento
23 h. influenzae oral pneumonias coverage middle ear fluid bovirhinis escherichia exhibited dolosigranulum cephalosporins abscess hajj pilgrims mab MRPA antiseptic
24 S. local M. adults tympanostomy m. bovirhinis patients probiotics asthma introduction previously subtype SM21 asp easily
25 results antibiotic resistance pathogen fluoroquinolones raom oprd transmission compounds rrna increased sore throat foodborne C. PPE/PE la
26 detection spectrum legionella pneumophila received URI mef(a persist resveratrol asymptomatic marcescens physician acquisition strain serology cfus
27 samples wide extrapulmonary clinicians sinusitis class enterococci cefoxitin aris recovered tonsillectomy wound human recorded por
28 streptococcus pneumoniae health factors made adenoid s. sonnei screening effect commensals HA-MRSA P. animals s. typhimurium χ3987 criteria lozenge
29 infections morbidity m. pneumoniae infection disease acute otitis analysis COPD biofilms yersinia HCAI urinary tract infection colonized vivo ICU es
30 respiratory viruses mechanisms countries mg/kg nasopharynx genes breath nalidixic interactions correlations f. necrophorum contamination clfa confirmed and/or
31 methods worldwide fever switch hearing loss dominant nosocomial infections ATCC core 1991 acnes coagulase-negative m. avium subsp sepsis penicillium
32 fluid leading pathogens rifampin otopathogen tuberculosis survive pigs disrupted glycopeptides sera participants in vivo AP otolaryngol
33 RESULTS streptococcus pneumoniae hospitalized cefdinir middle ear effusion performed gram-positive bactericidal activity phyla HCAI-MRSA J. methicillin-resistant antifungal molecular testing clínico
34 study prescribing macrolides rhinosinusitis tympanic FQ P. ag(+ dysbiosis dongguan metalworking arr binding RPH patient care
35 vaccine developing CRP penicillin polymicrobial jiangsu including antimicrobial pyrosequencing city ifn-α e. helvum immunity residents URTI
36 METHODS treatment mixed infections combination therapy dysfunction m. bovis episodes acid pseudotuberculosis teicoplanin man close expressing pseudomallei artificial
37 m. catarrhalis bronchitis l. pneumophila alternative age m. tuberculosis klebsiella pneumoniae bacteriostatic spring daptomycin UTI saudi fragment melioidosis haemolyticum
38 polymerase understanding c. pneumoniae gatifloxacin viruses arginini MRSA CFSM low-density hospitals F. argenteus TGEV yield hand hygiene
39 serotypes united states diagnostic proxetil adenoidectomy somni ventilator-associated pneumonia agar y. pestis nosocomial graft risks marneffei burkholderia non‐crs
40 pyogenes physicians investigations cefpodoxime non-aom streptomycin plants fructus probiotic IPD function saudi arabia recombinant contributing lo
41 conclusions pneumonia PCT loracarbef acute bacterial sinusitis non-tuberculous mycobacteria disinfection synergistic LPS isolates penicillin co-colonized il-1β total bla(oxa-51
42 rhinovirus respiratory coxiella clinical efficacy tympanostomy tube subtypes gram-positive organisms trimethoprim-sulfamethoxazole composition < urinary A4 alpha-toxin identified payne
43 associated with tract decision mild disease perforation harboured clostridium tilmicosin fall/winter significant child PGN adherence home multi-drug-resistant
44 reaction importance travelers cefuroxime insertion non-tuberculous klebsiella pneumonia phenolic young study pain 95%CI swine admitted cladosporium
45 BACKGROUND epidemiology viral cap alternate group bla acinetobacter species log(10 proteobacteria sonnei complications nigeria capable nursing los
46 patients emerging × axetil recurrences study stenotrophomonas vaginal firmicutes 2017 type dual tissues cohort surg
47 30 pneumococcus legionnaires ENT finom 100 exhaled breath combination prevotella IDS infection starting single-chain 117 entry
48 adenovirus treat disease excellent washes rates CB observed taxonomic s. flexneri 2a male MLST χ4509 diagnostic yield CRAB
49 bacterial culture oral cavity identified g/250 recurrence antimicrobial resistance maltophilia = cell surface antigens MIC90 streptococcal pharyngitis placebo virulence factor rdna bsis
50 syncytial bacterial 23S-5S cefixime development XDR-PA CF fermented overgrowth counts convalescent gradually amino-terminal radiological según